Uptake of tuberculosis prevention therapy in people living with HIV/AIDS in northern Nigeria: a programme to increase use of isoniazid preventive therapy
Background: Tuberculosis is a main cause of death in people living with HIV and results in around 39 000 deaths every year in Nigeria. Isoniazid preventive therapy (IPT), the standard tuberculosis preventive therapy used in Nigeria, has been shown to significantly reduce mortality and prevent tuberc...
Main Authors: | Fadimatu Yunusa, MPH, Maryam Bello, BSc, Gbenga A Kayode, PhD, Adeoye Adegboye, MPH, Geraldine Abone, MBBS, Fati Murtala-Ibrahim, B Pharm, Martha Okposo, MSc, Atinuke Anjorin, MBBS, Saswata Dutt, MBBS, Oche Yusuf, MHM, Nadia Sam-Agudu, Patrick Dakum, MPH |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-04-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X20301789 |
Similar Items
-
Effect of community treatment initiative on antiretroviral therapy uptake among linkage-resistant people living with HIV in Northern Nigeria
by: Moses Katbi, et al.
Published: (2019-10-01) -
Effect of clients Strategic Index Case Testing on community-based detection of HIV infections (STRICT study)
by: Moses Katbi, et al.
Published: (2018-09-01) -
Pellagra in isoniazid preventive and antiretroviral therapy
by: John Koech Kipsang, et al.
Published: (2019-01-01) -
Hyperglycaemia induced by isoniazid preventive therapy
by: Roshni Jhan Ganguly, et al.
Published: (2018-01-01) -
Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
by: Maria Elvira Balcells, et al.
Published: (2006-05-01)